Cellular Immune Responses in Triple-negative Breast Cancer - High Throughput Immunogenetic Studies
Cellular Immune Responses in Triple-negative Breast Cancer - High Throughput Immunogenetic Studies
Enrolling by invitation · NCT06646263 · Registry updated 2024-10-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Cellular Immune Responses in Triple-negative Breast Cancer - High Throughput Immunogenetic Studies | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Enrolling by invitation | Not stated | 2024-10-17 | NCT06646263 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hellenic Cooperative Oncology Group | 12 |
| Institute of Applied Biosciences | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Institute of Applied Biosciences | Thessaloniki | Greece | 1 |